Chinese Journal of New Drugs 2012 Issue 18 Drug development and government policy

Drug development and government policy
YE Xian-rong

..............page:2100-2103

The efficacy of low molecular weight heparin in sixty cancer patients with venous thromboembolism
DU Yong-liang1;WANG Yan2;LI Jun-ling2;PENG Yan1;MI Yu-ling1; XI Xiao-ming1;CHENG Fang1;WANG Qi1;ZHANG Xiang-ru2

..............page:2183-2188

Key problem in clinical trials of the new traditional Chinese medicine to treat primary osteoporosis
WANG Ting

..............page:2126-2127,2136

Effect of 5-hydroxytryptophane on depression in mice
BAO Nan-di1;HAN Yue1;BAI Hao1;ZHANG Bo2;LI Zhi-chao2;SUN Ri-he3

..............page:2141-2144

WINDOW OF NEW DRUGS

..............page:2091-2096

Determination of entrapment efficiency of forsythoside liposome by ultrafiltration
ZHUANG Ying-hua;ZHANG Zhong-wen;HAN Wei;WANG Hui-chuan;WU Guo-juan

..............page:2209-2211,2216

Protective effect of Shenankang capsule on acute renal failure in rats
GUO Ming;HOU Chuan-xiang;HAO Ling-ling;ZHENG Li-zhen

..............page:2202-2204

Some issues of non-inferiority clinical trials
HE Ying-chun;SUN Rui-yuan;ZHENG Qing-shan

..............page:2117-2120

Determination of L-isoleucine methyl ester hydrochloride in L-valine methyl ester hydrochloride by HPLC
YIN Jing;CHANG Yan

..............page:2137-2140

Drug risk communication method of America and Canada and its implication in China
LI Shan;YANG Yue

..............page:2104-2108

Progress in studies of antibiotic delivery systems to overcome bacterial resistance
CHEN Wei;WANG Yong-lu;LI Xue-ming;SUN Xiao-hu

..............page:2168-2172

Progress in preparation and clinical application of traditional Chinese medicine placebo
WU Fei;WANG You-jie;HONG Yan-long;FENG Yi;RUAN Ke-feng

..............page:2161-2164

Clinical efficacy and safety of paliperidone extended-release tablets in different dosage groups in the treatment of schizophrenia
LUO Ru-qin1;CHEN Ren-yun2

..............page:2193-2195,2208

Pharmacokinetics of the total alkaloid from linderae radix in rats
CHEN Jian-zhong1;2;WANG Chang-hong2;CHOU Gui-xin2;3;WANG Zheng-tao2;3

..............page:2145-2148,2155

US FDA’s regulatory system for drug manufacturing quality
HAN Liang1;2;Nicholas Buhay1;ZHENG Qiang1;3

..............page:2128-2136

Jasmonate,a new kind of anti-tumor drug
LI Xiao-ying;GAO Xian-shu

..............page:2156-2160

bian zhe tui jian
wang yu mei

..............page:2090

Progress in pharmacological and clinical studies of miriplatin on interventional therapy of hepatocellular carcinoma
ZHAO Jun;MA Jun-jie

..............page:2097-2099

Management of protocol deviation in clinical trials
BO Qing-yan1;XIE Li-qun2;XIONG Ning-ning1

..............page:2121-2125

Release kinetics of aciclovir resinate in vitro
LIU Hong-fei1;2;SHI Shuang-shuang1;ZHAO Xin1;SHEN Sheng1; HE Hao1;HUANG Hong-fei1;GAO Li1;PAN Wei-san2

..............page:2205-2208

Clinical research progress of pregabalin for acute postoperative pain
GENG Zhi-yu;WU Xin-min

..............page:2173-2177

Research progress of emerging monoclonal antibody drugs based on new technologies
WANG Zhi-ming;YANG Li-xia;JIA Yin-xing;HE Cheng

..............page:2149-2155

zhong guo hai yang yao wu za zhi 2013 nian zheng ding qi shi

..............page:2182

Effects of telmisartan administration time on blood pressure variability and left ventricular mass index in hypertensive patients
ZHAO Yan1;HAN Ning1;ZHAO Hong-min1;ZHANG Shi-ge2

..............page:2178-2182

A survey analysis of the knowledge-attitude-practice(KAP) of essential drugs in the view of patients
MA Jin-hua;XI Xiao-yu;CHU Shu-zhen

..............page:2109-2112,2120

Efficacy and safety of Dahuoluo capsules in the treatment of atherosclerotic thrombotic cerebral infarction
XU Shui-lian1;MENG Zhi-hong2;WANG De-hong1;DING Miao-qiang1; ZHU Yi-ning1;ZHOU Qi1;YAN Zhang-long1

..............page:2189-2192

Preparation of osmotic pump tablets of ambroxol hydrochloride using sulfobutylether-β-cyclodextrin as an osmotically active substance
CAO Ya-pei;HE Chao-xing;CAO De-ying

..............page:2212-2216

Mechanism study of rosiglitazone in the treatment of type 2 KKay diabetic mice
CONG Wen-juan1;SHEN Lan1;2;RUAN Ke-feng1;WANG Ling-yi1;ZHU Yun-yun1;FENG Yi1

..............page:2196-2201,2204

Advances in the study of hyaluronic acid and its derivatives used in drug delivery system
MENG Lu-hua;WANG Chi

..............page:2165-2167,2192

ge yi liao zai zhong guo he quan qiu tong bu shang shi xin yi dai ceng xi xi tong kta^tmpure

..............page:2188

zhong guo yao fang za zhi 2013 nian zheng ding qi shi

..............page:2125

ARO-CRO-SMO,a new better model serving clinical research
CHEN Jun-chao;LIU Hong-xia;Lü Ying-hua;ZHENG Qing-shan

..............page:2113-2116